LOGIN - EMDR: Eye Movement Desensitization and Reprocessing (EMDR) in Non-specific Chronic Back Pain

Sponsor
University Hospital Heidelberg (Other)
Overall Status
Completed
CT.gov ID
NCT01850875
Collaborator
(none)
40
1
2
31
1.3

Study Details

Study Description

Brief Summary

The study explores the feasibility of Eye-Movement-Desensitization and Reprocessing (EMDR) in non-specific chronic back pain.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Eye-Movement-Desensitization-Reprocessing
N/A

Detailed Description

The study explores the feasibility of Eye-Movement-Desensitization and Reprocessing (EMDR) in non-specific chronic back pain in a randomized controlled trial (RCT) with 6 months follow-up. The treatment consists of 12-sessions EMDR a 60 minutes using eye-movements for bilateral stimulation in addition to treatment as usual (TAU) that is compared to TAU alone.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Localized and Generalized Musculoskeletal Pain: Psychobiological Mechanisms and Implications for Treatment (LOGIN) - Subgroups Characterized by Psychological Trauma, Mental Comorbidity, and Psychobiological Patterns and Their Specialized Treatment - Eye Movement Desensitization and Reprocessing (EMDR) in Non-specific Chronic Back Pain
Study Start Date :
May 1, 2013
Actual Primary Completion Date :
Nov 1, 2014
Actual Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Eye-Movement-Desensitization-Reprocessing

Eye-Movement-Desensitization-Reprocessing

Behavioral: Eye-Movement-Desensitization-Reprocessing

No Intervention: Treatment as usual (control group)

treatment as usual

Outcome Measures

Primary Outcome Measures

  1. Change in pain intensity [Change from Baseline Pain intensity at average 6 months]

    Numerical rating scale 0-10

Other Outcome Measures

  1. functional and structural changes in fMRI [Change from Baseline fMRI at average 6 months]

  2. Change in the pain experience scale - Pain affect [Change from Baseline pain experience scale levels at average 6 months]

    Geisser et al., 1996

  3. Change in the Hannover functional ability questionnaire (FFbH) - disability [Change from Baseline disabilty levels at average 6 months]

    Kohlmann et al., 1996

  4. Change in Quantitative sensory testing (QST)profiles [Change from Baseline QST profile at average 6 months]

    According to the protocol by Rolke et al. (2006), developed within the Germany Research Network on Neuropathic Pain (DFNS)

  5. Change in Conditioned Pain Modulation [Change from Baseline conditioned pain modulation activity at average 6 months]

    difference in pressure pain threshold before and after oscillating heat (2 min.)

  6. Change in Plasma endocannabinoids and lipids [Change from Baseline endocannabinoids and lipids at average 6 months]

    Plasma levels: AEA (ng/ml), 2-AG (ng/ml), AA (ng/ml), PEA (ng/ml), OEA (ng/ml), AEA (pmol/g), 2-AG (pmol/g), AA (nmol/g), PEA (pmol/g), OEA (pmol/g),

  7. Change in plasma nerve growth factor levels [Change from Baseline NGF levels at average 6 months]

    Plasma levels in (pg/ml)

  8. Change in pain drawing/ the spatial extent of the pain [Change from Baseline Pain extent at average 6 months]

  9. Change in West Haven-Yale multidimensional pain inventory scores [Change from Baseline West Haven-Yale multidimensional pain inventory scores at average 6 months]

    Flor et al., 1990

  10. Change in chronic pain grade [Change from Baseline chronic pain grade at average 6 months]

    von Korff er al., 1992

  11. Change in Resilience Scale (RS-11) scores [Change from Baseline resilience scores at average 6 months]

    Schumacher et al., 2004

  12. Change in Hospital Anxiety and Depression Scale scores [Change from Baseline anxiety and depression levels at average 6 months]

    Zigmond & Snaith, 1983

  13. Change in Health Survey scores [Change from baseline quality of life level at average 6 months]

    SF-12

  14. Change in somatization scores [Change from Baseline somatization scores at average 6 months]

    SCL-90R

  15. Change in medication intake [Change from Baseline medication intake at average 6 months]

  16. Change in dissociation scores [Change from Baseline dissociation at average 6 months]

    DES/FDS-20

  17. Change in Post Traumatic Diagnostic Scale [Change from Baseline post traumatic diagnostic scale levels at average 6 months]

  18. Patient global impression of change [after on average 6 months of treatment]

  19. Recruitment potential [6 months]

    % of patients eligible for inclusion that give written informed consent

  20. Retention rate [over average 6 months of treatment]

    % of patients that finish treatment, including pre- and post-evaluation

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • = 18 years

  • non-specific chronic low back pain >= 45 days/3 months

  • high emotional distress caused by psychological trauma

  • German language skills

Exclusion Criteria:
  • specific causes of chronic back pain

  • application for retirement pension pending

  • ongoing psychotherapy

  • severe physical or psychiatric comorbidity

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital Heidelberg Heidelberg Baden-Württemberg Germany 69120

Sponsors and Collaborators

  • University Hospital Heidelberg

Investigators

  • Principal Investigator: Wolfgang Eich, Prof. Dr., University Hospital Heidelberg

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Prof. Dr. Wolfgang Eich, Prof. Dr., University Hospital Heidelberg
ClinicalTrials.gov Identifier:
NCT01850875
Other Study ID Numbers:
  • 01EC1010A
First Posted:
May 10, 2013
Last Update Posted:
May 16, 2016
Last Verified:
May 1, 2016
Keywords provided by Prof. Dr. Wolfgang Eich, Prof. Dr., University Hospital Heidelberg
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 16, 2016